Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Peripheral artery disease, an age-related ischemic disease, primarily affects the elderly. Cell therapy is a promising treatment for peripheral artery disease. This study aims to investigate the effects of macrophages derived from young mice on neovascularization and recovery in a hindlimb ischemia model of aged mice.
Methods: Monocytes were isolated from the bone marrow of young mice and cultured in vitro to generate bone marrow-derived macrophages. After polarization, young-derived M2-like bone marrow-derived macrophages were obtained. Aged mice were divided into 3 groups: saline group, young-derived nonpolarized bone marrow-derived macrophages group, and young-derived M2-like bone marrow-derived macrophages group. Hindlimb ischemia was induced in aged mice via femoral artery ligation. Three days after surgery, saline, young-derived nonpolarized bone marrow-derived macrophages, or young-derived M2-like bone marrow-derived macrophages were intramuscularly injected into the ischemic hindlimb. Doppler imaging, ischemia and mobility scores, and histological analysis were used to assess blood flow, functional recovery, and tissue repair. Neovascularization was further evaluated using micro-computed tomography and immunofluorescence staining.
Results: Compared with the saline group, aged mice in the young-derived M2-like bone marrow-derived macrophages group exhibited notable blood flow recovery, along with corresponding improvements in tissue and functional recovery. In addition, in terms of neovascularization, the young-derived M2-like bone marrow-derived macrophages group demonstrated a richer vascular bed, with significant increases in both arteriogenesis and angiogenesis, as well as enhanced endothelial cell function.
Conclusion: M2-like macrophages derived from young mice enhance neovascularization of aged mice with ischemia, leading to improved blood perfusion and tissue functional recovery. This suggests that macrophages represent a promising new therapeutic strategy for peripheral artery disease in the elderly.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.surg.2025.109460 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effects of Mesenchymal Stem Cell-Derived Exosomes on the Attenuation of Dry Eye Disease in Sjögren Syndrome Animal Model.
Tissue Eng Regen Med
September 2025
Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #505 BanPo-Dong, SeoCho-Gu, Seoul, 06591, Republic of Korea.
Background: Sjögren's syndrome (SS) is a chronic autoimmune disease delineated by excessive lymphocyte infiltration to the lacrimal or salivary glands, leading to dry eye and dry mouth. Exosomes secreted from mesenchymal stem cells (MSC) are known to have anti-inflammatory and tissue regeneration abilities. This study endeavored to demonstrate the effect of MSC-derived exosomes on the clinical parameter of dry eyes and associated pathology in SS mouse model.
View Article and Find Full Text PDFMitoribosome-Targeting Antibiotics Suppress Osteoclastogenesis and Periodontitis-Induced Bone Loss by Blocking Mitochondrial Protein Synthesis.
FASEB J
September 2025
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials
The onset and progression of periodontitis are closely related to metabolic reprogramming in the periodontal microenvironment, with osteoclasts playing a critical role in tissue destruction. Single-cell RNA sequencing (scRNA-seq) of periodontal tissues from healthy individuals and patients with severe chronic periodontitis revealed a significant increase in the expression of mitochondrial-related genes during osteoclast differentiation, suggesting the critical role of mitochondrial function in this process. This study investigates the potential of the novel mitoribosome-targeting antibiotic radezolid in inhibiting osteoclast differentiation.
View Article and Find Full Text PDFBorate-Ion-Stimulated Macrophages Promote Osteogenic Differentiation of Mesenchymal Stem Cells.
Adv Healthc Mater
September 2025
Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-cho, Showa-ku, Nagoya, 466-8555, Japan.
Immune cells, such as macrophages, stimulated by several types of inorganic ions released from bioactive glasses secrete cytokines that promote and inhibit bone formation. In this study, the effects of borate-ion-stimulated mouse macrophages (RAW264) on the osteogenic differentiation of mouse bone marrow-derived mesenchymal stem cells (KUSA-A1) are investigated. KUSA-A1 is cultured with a borate-ion-containing medium and RAW264-conditioned medium, which contained the secretome released from boron-stimulated RAW264, and its osteogenic differentiation is evaluated.
View Article and Find Full Text PDFClinical Efficacy of Stem Cell Therapy in Neurotraumatic and Neurodegenerative Conditions: A Comparative Review.
Tissue Eng Regen Med
September 2025
Department of Biomedical Science, Catholic Kwandong University, 24 Beomil-ro 579beon-gil, Gangneung-si, Gangwon-do, South Korea.
Background: Neurotraumatic conditions, such as spinal cord injury, brain injury, and neurodegenerative conditions, such as amyotrophic lateral sclerosis, pose a challenge to the field of rehabilitation for its complexity and nuances in management. For decades, the use of cell therapy in treatment of neurorehabilitation conditions have been explored to complement the current, mainstay treatment options; however, a consensus for standardization of the cell therapy and its efficacy has not been reached in the medical community. This study aims to provide a comparative review on the very topic of cell therapy use in neurorehabilitation conditions in an attempt to bridge the gap in knowledge.
View Article and Find Full Text PDFPotential Impact of Extracorporeal Photopheresis on Trained Immunity and Organ Transplant Acceptance.
Transplant Direct
September 2025
Unidad Transplante de О́rganos, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Extracorporeal photopheresis (ECP) is a well-established, safe, and effective immunomodulatory therapy currently used in clinics to decrease T cell-mediated immunity in various disorders, including autoimmune diseases and chronic rejection in organ transplantation. Although the ECP procedure has been shown to induce apoptotic cells that are reintroduced into the patient at the end of the treatment, the precise tolerogenic mechanisms mediated by ECP are not fully understood. Previous in vitro studies have demonstrated that early apoptotic cells express annexins on their cell surface, which suppress myeloid cell activation on stimulation with bacterial lipopolysaccharide through Toll-like receptors.
View Article and Find Full Text PDF